uniQure Aims to Begin First Human Trial of Investigational Gene Therapy AMT-130 for Huntington’s in 2018 – Huntington’s Disease News
|
uniQure Aims to Begin First Human Trial of Investigational Gene Therapy AMT-130 for Huntington's in 2018
Huntington’s Disease News uniQure expects to advance the clinical development of its Huntington's disease investigational gene therapy, called AMT-130, during 2018. The company says it plans to file an investigational new drug application (IND) with the U.S. Food and Drug … |
